Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Dutasteride caused more penile tissue changes than finasteride, possibly increasing erectile dysfunction risk.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Tadalafil is effective for treating urinary symptoms in men with BPH.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Hair loss linked to prostate enlargement; stress and family history important factors.

Gene variation affects prostate issues and hair loss.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Finasteride doesn't change rat testicle weight or sperm production.

International medical graduates outperformed U.S. graduates on an internal medicine exam.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Researchers created a simple tool to predict bladder blockage from prostate enlargement using urine flow rate and prostate volume.

Castration is preferred for non-breeding male dogs with BPH, but other treatments are available with specific pros and cons.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

Ginseng was more effective than finasteride in treating enlarged prostate in rats.

Finasteride affects prostate weights and pituitary activity differently with age.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Excessive hair growth in women, often from high androgen levels, is usually caused by PCOS, and can be treated with hair removal, medication, and possibly weight loss.

Finasteride reduces corpus cavernosum weight but doesn't affect erectile response in rats.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Finasteride can treat prostatic haematuria, but its use is controversial.

Ultra-high molecular weight poly-γ-glutamic acid may help promote hair growth.

Early treatment and weight management are important for teenagers with PCOS to reduce symptoms and long-term health risks.